Pulse Biosciences, Inc. Interest Income (Expense), Net
Pulse Biosciences, Inc. (PLSE) reported Interest Income (Expense), Net of -$517.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2021-08-09
- Pulse Biosciences, Inc. interest income (expense), net for the quarter ending 2021-06-30 was -$517.00K, a 2561.90% decline year-over-year.
- Pulse Biosciences, Inc. interest income (expense), net for the quarter ending 2021-03-31 was -$114.00K, a 246.15% decline year-over-year.
- Pulse Biosciences, Inc. interest income (expense), net for the quarter ending 2020-12-31 was $6.00K, a 95.80% decline year-over-year.
- Pulse Biosciences, Inc. interest income (expense), net for the quarter ending 2020-09-30 was $9.00K, a 95.87% decline year-over-year.
- Pulse Biosciences, Inc. interest income (expense), net for fiscal 2020 was $114.00K, a 88.40% decline from fiscal 2019.
- Pulse Biosciences, Inc. interest income (expense), net for fiscal 2019 was $983.00K, a 135.17% increase from fiscal 2018.
- Pulse Biosciences, Inc. interest income (expense), net for fiscal 2018 was $418.00K, a 69.23% increase from fiscal 2017.
- Pulse Biosciences, Inc. interest income (expense), net for fiscal 2017 was $247.00K, a 263.24% increase from fiscal 2016.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$517.00K 10-Q · filed 2021-08-09 | -$631.00K 10-Q · filed 2021-08-09 | -$625.00K derived: sum of 3 quarters · filed 2021-08-09 | -$616.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | -$114.00K 10-Q · filed 2021-05-10 | -$108.00K derived: sum of 2 quarters · filed 2021-05-10 | -$99.00K derived: sum of 3 quarters · filed 2021-05-10 | -$78.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $15.00K derived: sum of 2 quarters · filed 2021-03-12 | $36.00K derived: sum of 3 quarters · filed 2021-08-09 | $114.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | $9.00K 10-Q · filed 2020-11-09 | $30.00K derived: sum of 2 quarters · filed 2021-08-09 | $108.00K 10-Q · filed 2020-11-09 | $251.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-06-30 | $21.00K 10-Q · filed 2021-08-09 | $99.00K 10-Q · filed 2021-08-09 | $242.00K derived: sum of 3 quarters · filed 2021-08-09 | $460.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $78.00K 10-Q · filed 2021-05-10 | $221.00K derived: sum of 2 quarters · filed 2021-05-10 | $439.00K derived: sum of 3 quarters · filed 2021-05-10 | $729.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $143.00K 10-K · filed 2020-03-16 | $361.00K derived: sum of 2 quarters · filed 2020-11-09 | $651.00K derived: sum of 3 quarters · filed 2020-11-09 | $983.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $218.00K 10-Q · filed 2020-11-09 | $508.00K derived: sum of 2 quarters · filed 2020-11-09 | $841.00K 10-Q · filed 2020-11-09 | $947.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $290.00K 10-Q · filed 2020-08-10 | $622.00K 10-Q · filed 2020-08-10 | $729.00K derived: sum of 3 quarters · filed 2020-08-10 | $847.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $332.00K 10-Q · filed 2020-05-11 | $439.00K derived: sum of 2 quarters · filed 2020-05-11 | $557.00K derived: sum of 3 quarters · filed 2020-05-11 | $694.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $107.00K 10-K · filed 2020-03-16 | $225.00K derived: sum of 2 quarters · filed 2020-03-16 | $362.00K derived: sum of 3 quarters · filed 2020-03-16 | $418.00K 10-K · filed 2021-03-12 |
| 2018-09-30 | $118.00K 10-K · filed 2020-03-16 | $255.00K derived: sum of 2 quarters · filed 2020-03-16 | $311.00K 10-Q · filed 2019-11-07 | $439.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $137.00K 10-K · filed 2020-03-16 | $193.00K 10-Q · filed 2019-08-08 | $321.00K derived: sum of 3 quarters · filed 2020-03-16 | $360.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $56.00K 10-K · filed 2020-03-16 | $184.00K derived: sum of 2 quarters · filed 2020-03-16 | $223.00K derived: sum of 3 quarters · filed 2020-03-16 | $264.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $128.00K 10-K · filed 2019-03-14 | $167.00K derived: sum of 2 quarters · filed 2019-03-14 | $208.00K derived: sum of 3 quarters · filed 2019-03-14 | $247.00K 10-K · filed 2020-03-16 |
| 2017-09-30 | $39.00K 10-K · filed 2019-03-14 | $80.00K derived: sum of 2 quarters · filed 2019-03-14 | $119.00K 10-Q · filed 2018-11-01 | $153.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $41.00K 10-K · filed 2019-03-14 | $80.00K 10-Q · filed 2018-07-31 | $114.00K derived: sum of 3 quarters · filed 2019-03-14 | $145.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | $39.00K 10-K · filed 2019-03-14 | $73.00K derived: sum of 2 quarters · filed 2019-03-14 | $104.00K derived: sum of 3 quarters · filed 2019-03-14 | $107.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | $34.00K 10-K · filed 2018-03-16 | $65.00K derived: sum of 2 quarters · filed 2018-03-16 | $68.00K derived: sum of 3 quarters · filed 2018-03-16 | $68.00K 10-K · filed 2019-03-14 |
| 2016-09-30 | $31.00K 10-K · filed 2018-03-16 | $34.00K derived: sum of 2 quarters · filed 2018-03-16 | $35.00K 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $3.00K 10-K · filed 2018-03-16 | $3.00K 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |